NEU 0.26% $15.57 neuren pharmaceuticals limited

Updated MST report - target of $3.68 a share, page-148

  1. 1,005 Posts.
    lightbulb Created with Sketch. 193
    Most people who invest in a stock like NEU know how risky it is .. however, the risk has been mitigated by the science and the fact we are at the end of P3. A few years ago someone presented a thread on the percentage of drugs that are approved by the FDA which showed the closer you get to P3 and beyond the chances of being approved increase significantly. Acadia has apparently spent over 100 million funding this P3 test. The FDA has advised that if NEU matches the results in P2 we have a new drug. Now with all that being said, there is still no guarantees, hence my disdain for charts, bots, and all the other stuff. This is a classic binary event we either win or we lose. What happens in between doesn't matter

    GLA DYOR
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$15.57
Change
-0.040(0.26%)
Mkt cap ! $1.990B
Open High Low Value Volume
$15.83 $15.87 $15.20 $8.124M 524.8K

Buyers (Bids)

No. Vol. Price($)
1 64 $15.49
 

Sellers (Offers)

Price($) Vol. No.
$15.58 597 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.